Digital therapeutic is a digitized health solution, which utilizes digital and online health technologies to treat various medical and psychological conditions. It is a type of apps that helps patients and physicians track health data by modifying patient behavior as well as provide remote monitoring to improve long-term health problems. The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025 at a CAGR of 20.5% during the forecast period.

Factors that drive the growth of the global digital therapeutics market are growing need to control healthcare costs and upsurge in the incidence of chronic diseases. However, lack of awareness toward digital therapeutics acts as a key restraint to the market growth. On the contrary, high growth potential in the developing economies is anticipated to offer significant growth opportunities.

The global digital therapeutics market is segmented into the application, product, sales channel, and region. The applications covered in the study include diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. Based on product, the market is classified into software and devices. Depending on sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumer (B2C). Furthermore, the business-to-business (B2B) segment is categorized into employers, healthcare providers, and others. By business-to-consumers, the market is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By application, obesity segment is projected to be one of the most lucrative segments during the forecast period, owing to rise in obese population and increase in the number of cases where treatments is done via smartphone applications for obese population. For instance, according to the WHO, in 2016, more than 1.9 billion adults in the age group of 18 years and above, were overweight, and of these, over 650 million were obese. In addition, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers the largest exercise database, which helps reduce obesity. The analysis done by the Noom Inc. (offers mobile health coaching solutions) demonstrated that 78% of users lost weight.

Considering the product category, software is projected as one of the dominating segments, owing to the fact that software comprise the base of digital therapeutics and include different health-related apps and platforms. Moreover, software aid in transmitting a patient’s data from wearable devices to physicians via different electronic devices such as mobiles and tablets.Considering the product category, software is projected as one of the dominating segments, owing to the fact that software comprise the base of digital therapeutics and include different health-related apps and platforms. Moreover, software aid in transmitting a patient’s data from wearable devices to physicians via different electronic devices such as mobiles and tablets.

Based on region, North America dominated the global market in 2017 and is expected to retain its dominance throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Request for Table of Content

The global digital therapeutics market is in its nascent stage, and has gained significant attention over the past few years. The market has piqued the interest of healthcare providers, patients, and practioners, owing to several benefits offered by these devices to reduce healthcare expenditure, improve patient & doctor communication, and manage patient health efficiently. Moreover, there have been remarkable advances in the development of novel digital therapeutics applications to provide advanced management options of chronic disease patients and maintain a healthy lifestyle. As the market is saturated and is growing at a steady rate in the developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players in this market.

In addition, rapid penetration of smartphones is projected to increase the usage of digital therapeutics globally. At present, the developing economies have witnessed an increase in adoption of these devices for wellness management, such as fitness, diet & nutrition, and lifestyle & stress, which further boosts the growth of the market.